Ralph Lauren Q4 Earnings Coming Up: Is Now the Right Time to Buy? — Positive

RL   Zacks Investment Research — May 15, 2025

RL's fiscal Q4 results are likely to reflect strong brand momentum and digital growth, though currency headwinds may temper gains.

image for news Ralph Lauren Q4 Earnings Coming Up: Is Now the Right Time to Buy?

Birkenstock Q2: Strong Performance Negates Tariff Worries — Neutral

BIRK   Seeking Alpha — May 15, 2025

Birkenstock Holding plc delivered strong Q2 results, beating estimates and raising guidance, driven by robust brand strength and effective premiumization strategy. The company's financial health is solid, with healthy margins, strong interest coverage, and no liquidity concerns despite significant long-term debt. Birkenstock's pricing power and loyal customer base allow it to pass on tariff and inflation costs, turning challenges into opportunities.

image for news Birkenstock Q2: Strong Performance Negates Tariff Worries

First Solar Gains 56% in a Month: How Should You Play the Stock? — Neutral

FSLR   Zacks Investment Research — May 15, 2025

Investors interested in FSLR stock should wait for a more appropriate time, considering its premium valuation and downward earnings estimate revision.

image for news First Solar Gains 56% in a Month: How Should You Play the Stock?

Venture Global Seeks FERC Approval for Third LNG Plant in Louisiana — Positive

VG   Zacks Investment Research — May 15, 2025

VG plans to make a final investment decision on the CP2 plant, which is also its third liquefaction plant in Louisiana, subject to FERC???s approval.

image for news Venture Global Seeks FERC Approval for Third LNG Plant in Louisiana

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--FDA Approves Zynyz (retifanlimab-dlwr) the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States.

image for news Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States

Jaguar Health Reports First Quarter 2025 Financials — Neutral

JAGX   Accesswire — May 15, 2025

The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximately 6% versus net Q1 2024 revenue of $2.4 million and 37% versus net Q4 2024 revenue of $3.5 million Mytesi prescription volume increased by approximately 1.8% in Q1 2025 over Q1 2024 and decreased by approximately 13.5% in Q1 2025 over Q4 2024 REMINDER: Today Jaguar to host investor webcast at 4:15 p.m. Eastern regarding Q1 2025 financials and company updates; Click here to register Proof-of-concept (POC) results show crofelemer reduced total parenteral nutrition in patients with rare orphan diseases …

image for news Jaguar Health Reports First Quarter 2025 Financials

IOVA Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESS Newswire / May 15, 2025 / In a dramatic turn for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), investors watched the company's shares plunge nearly 44% on May 9, 2025, after the San Carlos-based cell therapy pioneer reported a first-quarter revenue miss that sharply contradicted earlier upbeat assurances from management. Hagens Berman is now investigating whether Iovance violated U.S. securities laws and urges Iovance investors who suffered substantial losses to submit your losses now.

image for news Lovance Biotherapeutics' (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% - Hagens Berman

SAN FRANCISCO, CA / ACCESS Newswire / May 15, 2025 / A federal securities class action lawsuit is moving forward against The Bancorp, Inc. (NASDAQ:TBBK), as investors who wish to seek appointment as lead plaintiff in the case must do so by May 16, 2025. The case, captioned Linden v.

image for news Bancorp (TBBK) Lawsuit: Investors Have Until May 16 to Claim Lead Role in Securities Case - Hagens Berman

NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your Ultra Clean Holdings, Inc. (NASDAQ:UCTT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ultra-clean-holdings-inc-lawsuit-submission-form?prid=148721&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

image for news Lost Money on Ultra Clean Holdings, Inc. (UCTT)? Contact Levi & Korsinsky to Join Class Action Before May 23, 2025

CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Income Statement Cosmos Health delivered solid results in Q1 2025, highlighted by a significant increase in gross profit and positive performance on both an Adjusted EBITDA and Adjusted Net Income basis, reflecting a meaningful turnaround in …

image for news RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

NEW YORK , May 15, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Foot Locker, Inc. (NYSE: FL ), relating to the proposed merger with DICK'S Sporting Goods, Inc. Under the terms of the agreement, Foot Locker shareholders will elect to receive either $24.00 in cash or 0.1168 shares of DICK'S common stock for each share of …

image for news SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Foot Locker, Inc. - FL

NEW YORK , May 15, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating NV5 Global, Inc. (NASDAQ: NVEE ), relating to the proposed merger with Acuren Corporation.

image for news $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of NV5 Global, Inc. - NVEE

CARLSBAD, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech or the “Company”) (NASDAQ: APCX), a fintech company, today announced its First Quarter 2025 financial results.

image for news AppTech Payments Corp. Highlights Q1 2025 Financial and Strategic Developments

LAKE OSWEGO, Ore. , May 15, 2025 /PRNewswire/ -- Umpqua Bank, a subsidiary of Columbia Banking System, Inc. (Nasdaq: COLB), today announced the appointment of Judi Giem to serve as Executive Vice President, Chief Human Resource Officer, effective June 2, 2025.

image for news Umpqua Bank Appoints Judi Giem as Executive Vice President, Chief Human Resource Officer

GEE Group Inc. (JOB) Q2 2025 Earnings Call Transcript — Neutral

JOB   Seeking Alpha — May 15, 2025

GEE Group Inc. (NYSE:JOB ) Q2 2025 Earnings Conference Call May 15, 2025 11:00 AM ET Company Participants Derek Dewan - Chairman and Chief Executive Officer Kim Thorpe - Senior Vice President and Chief Financial Officer Derek Dewan Hello and welcome to the GEE Group Fiscal 2025 Second Quarter and First Half Ended March 31, 2025 Earnings and Update Webcast Conference Call. I'm Derek Dewan, Chairman and Chief Executive Officer of GEE Group.

image for news GEE Group Inc. (JOB) Q2 2025 Earnings Call Transcript

Fund managers are less worried about an economic slowdown. That's why they loaded up on consumer, industrial, and tech stocks.

image for news Recession Odds Are Falling. Cheesecake Factory and 14 Other Stocks That Should Thrive

Nauticus Robotics, Inc. (KITT) Q1 2025 Earnings Call Transcript — Neutral

KITT   Seeking Alpha — May 15, 2025

Nauticus Robotics, Inc. (NASDAQ:KITT ) Q1 2025 Earnings Conference Call May 15, 2025 11:00 AM ET Company Participants Kristin Moorman - VP of Corporate Development & Administration John Gibson - President and Chief Executive Officer Victoria Hay - Interim Chief Financial Officer Daniel Dehart - Field Operations Leader Steve Walsh - Vice President of Sales Jason Close - Vice President of Autonomous Software Solutions Conference Call Participants Kunal Madhukar - Water Tower Research Operator Good day, ladies and gentlemen, and welcome to the Nauticus Robotics 2025 Q1 Earnings Conference Call. At this time, all lines are in listen-only mode.

image for news Nauticus Robotics, Inc. (KITT) Q1 2025 Earnings Call Transcript

CVS bids for Rite Aid stores, Bloomberg News reports — Positive

CVS   Reuters — May 15, 2025

Healthcare conglomerate CVS Health has bid for a significant number of stores and patient data from bankrupt pharmacy chain operator Rite Aid, Bloomberg News reported on Thursday.

image for news CVS bids for Rite Aid stores, Bloomberg News reports

Data Storage Corporation (DTST) Q1 2025 Earnings Call Transcript — Neutral

DTST   Seeking Alpha — May 15, 2025

Data Storage Corporation (NASDAQ:DTST ) Q1 2025 Earnings Conference Call May 15, 2025 11:00 AM ET Company Participants Alexandra Schilt - Investor Relations Chuck Piluso - Chairman and Chief Executive Officer Chris Panagiotakos - Chief Financial Officer Conference Call Participants Matthew Galinko - Maxim Group Adam Waldo - Lismore Partners Operator Greetings, and welcome to the Data Storage Corporation First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.

image for news Data Storage Corporation (DTST) Q1 2025 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company's positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financia.

image for news DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu